Recent Finacing
Recent Raise
IgGenix is a San Francisco biotech developing antibody therapeutics for IgE‑mediated allergies using a SeqSifter single‑cell genomics platform to isolate rare IgE B cells and reengineer allergen‑specific IgG
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
